Clinical Trial Update: Reference Group Trial for The ONE Study [Phase 4]

View source ↗

Summary

A Phase 4 reference group trial for The ONE Study sponsored by the University of Regensburg has completed, involving patients with end-stage renal disease and k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Rejection

Snippet

Sponsor: University of Regensburg | Conditions: End-stage Renal Failure, Kidney Graft Rejection | Phase 4 | Status: COMPLETED